Related News
Bristol-Myers Squibb names new BMS China president
By Ding Yining |
July 2, 2014, Wednesday
|
Online Edition
Online Edition
US biopharmaceutical company Bristol-Myers Squibb has named Karl Lintel as the new president of BMS China and its joint venture Sino-American Shanghai Squibb Pharmaceutical Co Ltd.
Lintel has acted as vice president and general manager of the company's Middle East and Africa unit since 2010.
He has also worked at UCB and Pfizer before joining BMS.
The US-based company said last year it plans to launch at least five new products in the next two years to drive sales in China.
- About Us
- |
- Terms of Use
- |
-
RSS - |
- Privacy Policy
- |
- Contact Us
- |
- Shanghai Call Center: 962288
- |
- Tip-off hotline: 52920043
- 娌狪CP璇侊細娌狪CP澶05050403鍙-1
- |
- 浜掕仈缃戞柊闂讳俊鎭湇鍔¤鍙瘉锛31120180004
- |
- 缃戠粶瑙嗗惉璁稿彲璇侊細0909346
- |
- 骞挎挱鐢佃鑺傜洰鍒朵綔璁稿彲璇侊細娌瓧绗354鍙
- |
- 澧炲肩數淇′笟鍔＄粡钀ヨ鍙瘉锛氭勃B2-20120012
Copyright 漏 1999- Shanghai Daily. All rights reserved.Preferably viewed with Internet Explorer 8 or newer browsers.
